However, the study of the possible effects of ADSCs modified to express IL-2 on B16F10 melanoma cell xenografts revealed that systemic injection of the modified MSCs also could effectively engraft into melanoma lung tumors but could not affect melanoma pulmonary metastases, and also the survival rate of the animal (58). This evidence concerns the gene IL2 and melanoma.